Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock EP.

JAMA. 2016 Aug 9;316(6):645-55. doi: 10.1001/jama.2016.6176. Review.

PMID:
27532919
2.

Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia.

Ogura M, Hori M, Harada-Shiba M.

Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):181-8. doi: 10.1161/ATVBAHA.115.306665.

PMID:
26543100
3.

The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study.

Hovingh GK, Smits LP, Stefanutti C, Soran H, Kwok S, de Graaf J, Gaudet D, Keyserling CH, Klepp H, Frick J, Paolini JF, Dasseux JL, Kastelein JJ, Stroes ES.

Am Heart J. 2015 May;169(5):736-742.e1. doi: 10.1016/j.ahj.2015.01.008.

PMID:
25965722
4.

Elevated atherosclerosis-related gene expression, monocyte activation and microparticle-release are related to increased lipoprotein-associated oxidative stress in familial hypercholesterolemia.

Hjuler Nielsen M, Irvine H, Vedel S, Raungaard B, Beck-Nielsen H, Handberg A.

PLoS One. 2015 Apr 13;10(4):e0121516. doi: 10.1371/journal.pone.0121516.

5.

Prolonged combination lipid therapy is associated with reduced carotid intima-media thickness: a case-control study of the 20-year Familial Atherosclerosis Treatment - Observational Study (FATS-OS).

Phan BA, Moore AB, Davis J, Pollan LJ, Neradilek B, Brown BG, Zhao XQ.

J Clin Lipidol. 2014 Sep-Oct;8(5):489-93. doi: 10.1016/j.jacl.2014.07.004.

6.

[Two forms of familial hypercholesterolemia: differences in cardiovascular risk factors, cardiac and extracardiac atherosclerosis].

Vogt A, Keller C, Heigl C, Weiss N, Zöllner N.

Dtsch Med Wochenschr. 2014 Dec;139(50):2573-7. doi: 10.1055/s-0034-1387237. German.

PMID:
25126774
7.

Statins for children with familial hypercholesterolemia.

Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E.

Cochrane Database Syst Rev. 2014 Jul 23;(7):CD006401. doi: 10.1002/14651858.CD006401.pub3. Review.

PMID:
25054950
8.

Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review.

Narverud I, Retterstøl K, Iversen PO, Halvorsen B, Ueland T, Ulven SM, Ose L, Aukrust P, Veierød MB, Holven KB.

Atherosclerosis. 2014 Aug;235(2):299-309. doi: 10.1016/j.atherosclerosis.2014.05.917. Review.

PMID:
24908240
9.

[Lipoprotein(a) is associated to atherosclerosis in primary hypercholesterolemia].

Bea AM, Mateo-Gallego R, Jarauta E, Villa-Pobo R, Calmarza P, Lamiquiz-Moneo I, Cenarro A, Civeira F.

Clin Investig Arterioscler. 2014 Jul-Aug;26(4):176-83. doi: 10.1016/j.arteri.2014.01.001. Spanish.

PMID:
24576773
10.

Carotid intima-media thickness in children with familial hypercholesterolemia.

Kusters DM, Wiegman A, Kastelein JJ, Hutten BA.

Circ Res. 2014 Jan 17;114(2):307-10. doi: 10.1161/CIRCRESAHA.114.301430.

11.

Inheritance pattern of familial hypercholesterolemia and markers of cardiovascular risk.

Kusters DM, Avis HJ, Braamskamp MJ, Huijgen R, Wijburg FA, Kastelein JJ, Wiegman A, Hutten BA.

J Lipid Res. 2013 Sep;54(9):2543-9. doi: 10.1194/jlr.M034538.

12.

Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia.

Vlahos AP, Naka KK, Bechlioulis A, Theoharis P, Vakalis K, Moutzouri E, Miltiadous G, Michalis LK, Siamopoulou-Mavridou A, Elisaf M, Milionis HJ.

Pediatr Cardiol. 2014 Jan;35(1):63-70. doi: 10.1007/s00246-013-0742-0.

PMID:
23821294
13.

Intima-media thickness correlates with features of metabolic syndrome in young people with a clinical diagnosis of familial hypercholesterolaemia.

Waluś-Miarka M, Wojciechowska W, Miarka P, Kloch-Badełek M, Woźniakiewicz E, Czarnecka D, Sanak M, Małecki M, Idzior-Waluś B.

Kardiol Pol. 2013;71(6):566-72. doi: 10.5603/KP.2013.0119.

14.

Early-onset plasmapheresis and LDL-apheresis provide better disease control for pediatric homozygous familial hypercholesterolemia than HMG-CoA reductase inhibitors and ameliorate atherosclerosis.

Dann EJ, Shamir R, Mashiach T, Shaoul R, Badian A, Stravets T, Kerzman Y, Finkelbaum S, Gaitini D, Lorber A, Bonstein L.

Transfus Apher Sci. 2013 Oct;49(2):268-77. doi: 10.1016/j.transci.2013.05.001.

PMID:
23791799
15.

First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene.

Al-Hinai AT, Al-Abri A, Al-Dhuhli H, Al-Waili K, Al-Sabti H, Al-Yaarubi S, Al-Hashmi K, Banerjee Y, Al-Zakwani I, Al-Rasadi K.

Angiology. 2013 May;64(4):287-92. doi: 10.1177/0003319712465171.

PMID:
23162007
16.

Statin treatment of children with familial hypercholesterolemia--trying to balance incomplete evidence of long-term safety and clinical accountability: are we approaching a consensus?

Vuorio A, Docherty KF, Humphries SE, Kuoppala J, Kovanen PT.

Atherosclerosis. 2013 Feb;226(2):315-20. doi: 10.1016/j.atherosclerosis.2012.10.032. Review.

PMID:
23141908
17.

Guidelines for the management of familial hypercholesterolemia.

Harada-Shiba M, Arai H, Oikawa S, Ohta T, Okada T, Okamura T, Nohara A, Bujo H, Yokote K, Wakatsuki A, Ishibashi S, Yamashita S.

J Atheroscler Thromb. 2012;19(12):1043-60.

18.

Assessment of carotid atherosclerosis in normocholesterolemic individuals with proven mutations in the low-density lipoprotein receptor or apolipoprotein B genes.

Huijgen R, Vissers MN, Kindt I, Trip MD, de Groot E, Kastelein JJ, Hutten BA.

Circ Cardiovasc Genet. 2011 Aug 1;4(4):413-7. doi: 10.1161/CIRCGENETICS.110.959239.

19.

Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.

Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP.

Int Angiol. 2011 Jun;30(3):295; author reply 296. No abstract available.

PMID:
21617615
20.

Clinical perspective: have the results of recent clinical trials of lipid-lowering therapies influenced the way we should practice? A Latin American perspective of current issues in clinical lipidology.

Santos RD, Lorenzatti AJ, Barros CF, Escobar E; discussants from a Clinical Lipidology Roundtable of Latin American Physicians..

J Clin Lipidol. 2011 May-Jun;5(3):124-32. doi: 10.1016/j.jacl.2011.02.006. Review.

PMID:
21600516
Items per page

Supplemental Content

Loading ...
Support Center